1

Strategic use of statistical thinking in drug development

Year:
2000
Language:
english
File:
PDF, 50 KB
english, 2000
2

Industry perspectives on ICH guidelines

Year:
2002
Language:
english
File:
PDF, 63 KB
english, 2002
3

ICH-E9 reflections and considerations

Year:
2008
Language:
english
File:
PDF, 76 KB
english, 2008
7

Requiring ‘independent’ statistical analyses for industry sponsored trials?

Year:
2006
Language:
english
File:
PDF, 69 KB
english, 2006
8

10 Years with ICH E10: Choice of Control Groups

Year:
2011
Language:
english
File:
PDF, 57 KB
english, 2011
13

Trial summaries on results databases and journal publication

Year:
2006
Language:
english
File:
PDF, 681 KB
english, 2006
14

Public disclosure of clinical research

Year:
2009
Language:
english
File:
PDF, 50 KB
english, 2009
16

Access to Patient-Level Data from GlaxoSmithKline Clinical Trials

Year:
2013
Language:
english
File:
PDF, 401 KB
english, 2013
17

Public Disclosure of Clinical Trial Results

Year:
2009
Language:
english
File:
PDF, 107 KB
english, 2009
20

Panel discussion of case study 3

Year:
2005
Language:
english
File:
PDF, 1.61 MB
english, 2005
21

The Society for Clinical Trials supports United States legislation mandating trials registration

Year:
2005
Language:
english
File:
PDF, 151 KB
english, 2005
22

Clinical Trials Registration

Year:
2006
Language:
english
File:
PDF, 49 KB
english, 2006
30

Data Sharing at a Crossroads

Year:
2016
Language:
english
File:
PDF, 72 KB
english, 2016
31

Comments on ‘Estimands in clinical trials - broadening the perspective’

Year:
2017
Language:
english
File:
PDF, 60 KB
english, 2017
45

Open science: The open clinical trials data journey

Year:
2019
Language:
english
File:
PDF, 323 KB
english, 2019